Clinical Trials Directory

Trials / Completed

CompletedNCT03373344

Remediation of Emotional Processing Deficits in MS

Remediation of Emotional Processing Deficits in MS: A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Kessler Foundation · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study will test the effectiveness of an emotional processing intervention in individuals with MS in a double blind placebo controlled randomized clinical trial. We will utilize an intervention which has been successfully used in other populations, including Schizophrenia and Traumatic Brain Injury. Our pilot data shows that this intervention is effective in individuals with MS as well

Detailed description

This study will test the effectiveness of an emotional processing intervention in individuals with MS in a double blind placebo controlled randomized clinical trial RCT). We will utilize an intervention which has been successfully used in other populations, including Schizophrenia and Traumatic Brain Injury. Our pilot data shows that this intervention is effective in individuals with MS, as well. All participants will undergo a baseline evaluation assessing emotional processing abilities, cognitive functioning, and psychological functioning. Participants will then be randomized into two groups. During the treatment phase, the experimental group will receive the proposed intervention while the control group will receive a "placebo" treatment. Neuropsychological assessment will be repeated at the end of the intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEmotional Processing TrainingParticipants in the experimental group will receive computerized exercises administered on a laptop computer. They will undergo 12 sessions of 45-60 minutes each (twice a week for 6 weeks).
BEHAVIORALPlacebo control exercisesParticipants in the control group will receive computerized control exercises administered on a laptop computer. They will undergo 12 sessions of 45-60 minutes each (twice a week for 6 weeks).

Timeline

Start date
2016-11-01
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2017-12-14
Last updated
2020-07-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03373344. Inclusion in this directory is not an endorsement.